Jagsonpal Pharmaceuticals Board of Directors
Get the latest insights into the leadership at Jagsonpal Pharmaceuticals. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Rajpal Singh Kochhar | Chairman Emeritus |
| Mr. Harsha Raghavan | Chairman & Non-Exe.Director |
| Mr. Manish Gupta | Managing Director |
| Mr. Prithipal Singh Kochhar | Non Executive Director |
| Mr. Debasis Bikash Nandy | Independent Director |
| Ms. Radhika Madhukar Dudhat | Independent Director |
| Ms. Pallavi Dinodia Gupta | Independent Director |
Jagsonpal Pharmaceuticals Share price
JAGSNPHARM
242.3
6.01 (-2.42%)NSE
BSE
Last updated on 4 Sep, 2025 | 15:42 IST
BUYSELL
Today's High
250.61
Today's Low
238.90
52 Week Low
153.10
52 Week High
328.04
The current prices are delayed, login to your account for live prices
LoginJagsonpal Pharmaceuticals FAQs
The board at Jagsonpal Pharmaceuticals consists of experienced professionals, including Mr. Rajpal Singh Kochhar , Mr. Harsha Raghavan , and others, overseeing the company’s strategic and corporate governance.
Directors at Jagsonpal Pharmaceuticals are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Rajpal Singh Kochhar is the current chairman at Jagsonpal Pharmaceuticals.
Executive directors at Jagsonpal Pharmaceuticals are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Jagsonpal Pharmaceuticals adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Jagsonpal Pharmaceuticals, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.